Amedeo Smart

Free Medical Literature Service

 

Amedeo

Liver Diseases
  Free Subscription

Articles published in
Am J Gastroenterol
    April 2026
  1. KAO KD, Troost JP, Yang JD, Salgia R, et al
    Patient Preferences in Hepatocellular Carcinoma Surveillance: A Multi-site Conjoint Analysis.
    Am J Gastroenterol. 2026 Apr 10. doi: 10.14309/ajg.0000000000004023.
    >> Share

  2. LEE D, Maravic Z, Moon AM, Langenbacher D, et al
    Enhancing Patient Empowerment Through Artificial Intelligence in Liver Cancer.
    Am J Gastroenterol. 2026;121:847-854.
    >> Share

    March 2026
  3. JOHNSON PJ, Kalyuzhnyy A, Grauslys A, Toyoda H, et al
    Predicting the Risk of Decompensation in Patients with Cirrhosis - a Validated Machine Learning Approach.
    Am J Gastroenterol. 2026 Mar 25. doi: 10.14309/ajg.0000000000004004.
    >> Share

  4. SILVEY S, Patel N, Tsai SY, Nadeem M, et al
    Correction to Higher Rate of Spontaneous Bacterial Peritonitis Recurrence With Secondary Spontaneous Bacterial Peritonitis Prophylaxis Compared With No Prophylaxis in 2 National Cirrhosis Cohorts.
    Am J Gastroenterol. 2026 Mar 9. doi: 10.14309/ajg.0000000000003941.
    >> Share

  5. MIYOSHI Y, Nishio A, Tatsumi N, Yoshida Y, et al
    Ciliated Hepatic Foregut Cyst with Clustered Echogenic Foci: An Incidental Finding on Health Screening.
    Am J Gastroenterol. 2026 Mar 6. doi: 10.14309/ajg.0000000000003993.
    >> Share

  6. YOHEI H, Sakaue T, Yoshimura S, Takedatsu H, et al
    A Continuous Metallic Stream: Endoscopic Salvage of Migrated Hepatic Artery Coils.
    Am J Gastroenterol. 2026 Mar 5. doi: 10.14309/ajg.0000000000003989.
    >> Share

  7. BAJAJ JS, Jakab SS, Jesudian AB, Rahimi RS, et al
    ACG Clinical Guideline: Hepatic Encephalopathy.
    Am J Gastroenterol. 2026;121:588-618.
    >> Share

  8. BARRITT AS 4TH, Tapper EB, Newsome PN, Gazis D, et al
    Cardiovascular Risk Assessment Tools are Insufficient for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Am J Gastroenterol. 2026;121:710-719.
    >> Share

  9. JOHN BV, Bastaich D, Marchetti D, Perumalswami P, et al
    Association of Glucagon-Like Peptide-1 Receptor Agonists With Liver-Related Outcomes and All-Cause Mortality in Patients With Harmful Alcohol Use: A Target Trial Emulation Study.
    Am J Gastroenterol. 2026;121:697-709.
    >> Share

    February 2026
  10. OCHOA-ALLEMANT P, Kiran A, Mezzacappa C, Kaplan DE, et al
    Steatotic Liver Disease Has Surpassed Viral Hepatitis as the Leading Cause of Cirrhosis in the U.S. Veterans Health System.
    Am J Gastroenterol. 2026 Feb 18. doi: 10.14309/ajg.0000000000003966.
    >> Share

  11. TAPPER EB, Woodrell CD, Rakoski M, Huang R, et al
    Hepatic Encephalopathy is the Key Driver of Symptom Burden in a Longitudinal Cohort of Patients with Advanced Chronic Liver Disease: PAL-LIVER sub-study.
    Am J Gastroenterol. 2026 Feb 13. doi: 10.14309/ajg.0000000000003964.
    >> Share

  12. PATEL N, Silvey S, Bajaj JS
    Vonoprazan Is Associated with Better Liver-Related Outcomes Compared to Proton Pump Inhibitors In Cirrhosis.
    Am J Gastroenterol. 2026 Feb 10. doi: 10.14309/ajg.0000000000003945.
    >> Share

  13. CAVIGLIA GP, Ferro A, D'Ambrosio R, Perbellini R, et al
    Effectiveness of a Model of Care Based on Fibrosis-4 and Liver Stiffness Measurement for the Screening of Patients With Type 2 Diabetes Mellitus at Risk of Advanced Liver Disease: Results From an Italian Prospective Multicenter Study.
    Am J Gastroenterol. 2026;121:375-382.
    >> Share

  14. ALKHOURI N, Cheuk-Fung Yip T, Castera L, Takawy M, et al
    ALADDIN: A Machine Learning Approach to Enhance the Prediction of Significant Fibrosis or Higher in Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Am J Gastroenterol. 2026;121:362-374.
    >> Share

    January 2026
  15. SHABBIR R, Garrido-Trevino L, O'Leary JG, Chaudhary A, et al
    MELD-Lactate and lactate clearance in critically ill cirrhosis patients with sepsis.
    Am J Gastroenterol. 2026 Jan 27. doi: 10.14309/ajg.0000000000003934.
    >> Share

  16. JARRAH M, Rich NE, Figueroa G, Garces SM, et al
    Treatment Delays and Survival in Patients with Hepatocellular Carcinoma: A Multicenter Cohort Study.
    Am J Gastroenterol. 2026 Jan 21. doi: 10.14309/ajg.0000000000003923.
    >> Share

  17. XUE J, Zhang L, Xie N, Lei L, et al
    Primary hepatic somatostatinoma (G2) with diabetes and nodal metastasis: An exceptionally rare primary liver tumor.
    Am J Gastroenterol. 2026 Jan 9. doi: 10.14309/ajg.0000000000003908.
    >> Share

  18. SHROFF H, Shankar A, Baron A, Yoxheimer L, et al
    A Large Language Model Assistant for Summarizing Hepatology Referral Documents.
    Am J Gastroenterol. 2026 Jan 8. doi: 10.14309/ajg.0000000000003905.
    >> Share

  19. AHMAD J, Dellinger A, Nicoletti P, Barnhart HX, et al
    Clinical and HLA Associations of Fluoroquinolone-Induced Liver Injury: Results From the Drug-Induced Liver Injury Network.
    Am J Gastroenterol. 2026;121:151-158.
    >> Share

  20. LE P, Tatar M, Rothberg MB, Wilson LA, et al
    Association of Components of Metabolic Syndrome and the Progression of Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2026;121:159-170.
    >> Share

    December 2025
  21. SHROFF H, Fix OK
    Practical Applications of Artificial Intelligence to Improve Efficiency and Reduce Burnout in Gastroenterology and Hepatology Practices.
    Am J Gastroenterol. 2025 Dec 16. doi: 10.14309/ajg.0000000000003887.
    >> Share

  22. CHOI J, Nguyen VH, Przybyszewski E, Song J, et al
    Association of SGLT2 Inhibitors with Reduced Hepatocellular Carcinoma Risk in Patients with Type 2 Diabetes.
    Am J Gastroenterol. 2025 Dec 16. doi: 10.14309/ajg.0000000000003889.
    >> Share

  23. ABU-RUMAILEH M, Dhoop S, Pace J, Qapaja T, et al
    Social Determinants of Health Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence and Severity: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2025;120:2810-2820.
    >> Share

    November 2025
  24. RODRIGUEZ N, Katzenstein C, Alpert L, Sigel K, et al
    Evaluating the 2023 EASL guidelines for intrahepatic cholestasis of pregnancy: risk stratification and outcomes in over 4,000 U.S. patients.
    Am J Gastroenterol. 2025 Nov 24. doi: 10.14309/ajg.0000000000003866.
    >> Share

  25. PATIDAR KR, Hall L, Ogola GO, Pike F, et al
    Associations Between Mean Arterial Pressure Thresholds and Clinical Outcomes in Decompensated Cirrhosis With Septic Shock.
    Am J Gastroenterol. 2025 Nov 19. doi: 10.14309/ajg.0000000000003854.
    >> Share

  26. SWAIN LA, Godley J, Wang M, Brahmania M, et al
    Temporal and demographic trends in alcohol-related-cirrhosis, alcohol-related hepatitis, and non-alcohol-related cirrhosis hospitalizations from 2012-2023: A population-based study in Alberta, Canada.
    Am J Gastroenterol. 2025 Nov 14. doi: 10.14309/ajg.0000000000003835.
    >> Share

  27. SMITH L, Sciacca K, Durieux BN, Bizup G, et al
    Harnessing Natural Language Processing to Identify Documentation of Serious Illness Communication for Patients with Decompensated Cirrhosis.
    Am J Gastroenterol. 2025 Nov 14. doi: 10.14309/ajg.0000000000003830.
    >> Share

  28. SILVEY S, Patel N, Davis BC, Sterling RK, et al
    Use of Natural language processing to objectively identify hepatic encephalopathy in multiple cohorts.
    Am J Gastroenterol. 2025 Nov 6. doi: 10.14309/ajg.0000000000003824.
    >> Share

  29. BURTON R, Leggio L, Louvet A, Sheron N, et al
    Prevention of Alcohol-Associated Liver Disease.
    Am J Gastroenterol. 2025;120:2487-2501.
    >> Share

  30. JOHN BV, Bastaich D, Mezzacappa C, Ferreira RD, et al
    Identifying Metabolic Dysfunction-Associated Steatotic Liver Disease Using Natural Language Processing in a US National Cohort.
    Am J Gastroenterol. 2025;120:2583-2591.
    >> Share

  31. SHENOY A, Jasty VS, Uttal S, Nasser S, et al
    Medications for Alcohol Use Disorder Are Increasingly Being Prescribed in American Patients With Advanced Liver Disease.
    Am J Gastroenterol. 2025;120:2576-2582.
    >> Share

  32. NIEZEN S, Morgan TR, Scott D, Yakovchenko V, et al
    Identifying and Treating Metabolic Dysfunction-Associated Steatotic Liver Disease Among At-Risk Veterans.
    Am J Gastroenterol. 2025;120:2559-2566.
    >> Share

    October 2025
  33. DE FARIA MORAES B, Pedral Diniz Leite GA, Pedral Diniz Leite GA, Motta Fonseca ML, et al
    Reevaluating the Role of Proton Pump Inhibitors After Endoscopic Band Ligation of Esophageal Varices in Cirrhotic Patients: A Systematic Review and Meta-analysis.
    Am J Gastroenterol. 2025 Oct 21. doi: 10.14309/ajg.0000000000003800.
    >> Share

  34. CHIRAPONGSATHORN S, Chang A, Malikhao S, Wanichagool D, et al
    One versus five days of octreotide infusion for acute esophageal variceal bleeding: a randomized controlled trial.
    Am J Gastroenterol. 2025 Oct 15. doi: 10.14309/ajg.0000000000003791.
    >> Share

  35. ZHANG X, Ning C, Yang X
    The Illusion of Response: Diffuse Hepatic Metastasis Masked by Shrinking Lesions in Neuroendocrine Carcinoma of the Cervix.
    Am J Gastroenterol. 2025 Oct 10. doi: 10.14309/ajg.0000000000003788.
    >> Share

  36. BOIKE JR, Gallegos-Orozco JF, Duarte-Rojo A
    Rallentando un Poco : Carvedilol and Its Role in Cirrhosis Progression.
    Am J Gastroenterol. 2025 Oct 3. doi: 10.14309/ajg.0000000000003765.
    >> Share

  37. KHAN Z
    Continuing Medical Education Questions: October 2025.
    Am J Gastroenterol. 2025;120:2236.
    >> Share

  38. RATTAN P, Ahn JC, Chara BS, Mullan AF, et al
    Training and Performance of an Electrocardiogram-Enabled Machine Learning Model for Detection of Advanced Chronic Liver Disease.
    Am J Gastroenterol. 2025;120:2452-2456.
    >> Share

  39. LEE HH, Lee HA, Kim EJ, Kim HY, et al
    Cardiovascular Risk From Metabolic Dysfunction-Associated Steatotic Liver Disease, Cardiometabolic Risk Factor Count, and Their Longitudinal Changes: A Nationwide Cohort Study.
    Am J Gastroenterol. 2025;120:2321-2329.
    >> Share

  40. WU C, Targher G, Byrne CD, Mao Y, et al
    Global, Regional, and National Burden of Primary Liver Cancer Attributable to Metabolic Risks: An Analysis of the Global Burden of Disease Study 1990-2021.
    Am J Gastroenterol. 2025;120:2280-2290.
    >> Share

  41. KIM WR, Mannalithara A, Charu V, Chung N, et al
    Optimal Population Screening Strategies for Liver Fibrosis Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Am J Gastroenterol. 2025;120:2312-2320.
    >> Share

  42. LUTZ MK, Caldera F
    Vaccination Outcomes and Recommendations Among Older Adults in a Gastroenterology and Hepatology Practice.
    Am J Gastroenterol. 2025;120.
    >> Share

  43. BROWN CL, Bajaj JS
    Considerations in the Diagnoses and Management of Hepatic Disease in Older Adults.
    Am J Gastroenterol. 2025;120.
    >> Share

    September 2025
  44. PATEL AA, O'Leary JG, Bajaj JS, Prause N, et al
    Increasing Goals of Care Discussions Among Veterans with Cirrhosis: A Veterans Health Administration Quality Improvement Initiative.
    Am J Gastroenterol. 2025 Sep 29. doi: 10.14309/ajg.0000000000003781.
    >> Share

  45. HASJIM BJ, Patel M, Chen S, Ichii H, et al
    Social Determinants of Health and Liver Transplant Outcomes in U.S. Indigenous Populations.
    Am J Gastroenterol. 2025 Sep 26. doi: 10.14309/ajg.0000000000003770.
    >> Share

  46. MAHMUD N, Fricker ZP, McElroy LM, Qayed E, et al
    ACG Clinical Guideline: Perioperative Risk Assessment and Management in Patients With Cirrhosis.
    Am J Gastroenterol. 2025;120:1968-1984.
    >> Share

  47. NIU C, Sun K, Zhang J, Elkhapery A, et al
    Gastrointestinal and Hepatobiliary Safety of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes.
    Am J Gastroenterol. 2025 Sep 3. doi: 10.14309/ajg.0000000000003760.
    >> Share

    August 2025
  48. JEFFREY AW, Majumdar A, Jeffrey G, Calzadilla-Bertot L, et al
    The Portal Hypertension Decompensation Score - A Validated Predictive Model of Liver Decompensation Related to Portal Hypertension.
    Am J Gastroenterol. 2025 Aug 22. doi: 10.14309/ajg.0000000000003744.
    >> Share

  49. PRAKASH JH, Anirvan P, Gupta S, Chouhan MI, et al
    Diagnostic Accuracy of Spleen-dedicated 100 Hz Transient Elastography to Predict High-risk Esophageal Varices.
    Am J Gastroenterol. 2025 Aug 22. doi: 10.14309/ajg.0000000000003741.
    >> Share

    July 2025
  50. RANA R, Tabish M, Agarwal S, Bayye R, et al
    Simvastatin addition to standard of care improves long-term survival in patients with cirrhosis after variceal bleed: An open label randomized controlled trial.
    Am J Gastroenterol. 2025 Jul 31. doi: 10.14309/ajg.0000000000003689.
    >> Share

  51. OUYANG MM G, Chen Mm X, Yao Mm X, Mo Mm X, et al
    Unprecedented Duodenal Erosion of a Transjugular Intrahepatic Portosystemic Shunt Stent: A Rare Trigger for Recurrent Polymicrobial Sepsis.
    Am J Gastroenterol. 2025 Jul 30. doi: 10.14309/ajg.0000000000003680.
    >> Share

  52. NGUYEN NV, Sandstrom A, Dominicus A, Mageau A, et al
    Thiopurines and intrahepatic cholestasis of pregnancy in systemic lupus erythematosus and inflammatory bowel disease pregnancies.
    Am J Gastroenterol. 2025 Jul 23. doi: 10.14309/ajg.0000000000003652.
    >> Share

  53. KHAJURIA R, Jindal A, Sharma MK, Arora V, et al
    Efficacy and safety of carvedilol in cirrhosis patients with new-onset uncomplicated ascites without high-risk esophageal varices. (CARVE-AS Trial).
    Am J Gastroenterol. 2025 Jul 21. doi: 10.14309/ajg.0000000000003650.
    >> Share

  54. WOLTSCHE J, Pacher-Deutsch C, Furst S, Gulden L, et al
    Microbial Dysbiosis in the Urinary Microbiome of Patients with Cirrhosis.
    Am J Gastroenterol. 2025 Jul 7. doi: 10.14309/ajg.0000000000003634.
    >> Share

  55. ZHANG K, Zhang L, Zhang J, Lu X, et al
    Unexpected Origin: Gastric Mature Cystic Teratoma Presenting as a Hepatic Mass.
    Am J Gastroenterol. 2025 Jul 2. doi: 10.14309/ajg.0000000000003621.
    >> Share

    June 2025
  56. CHAPMAN B, Sinclair M, Majumdar A, Yu C, et al
    Real-world experience of home continuous terlipressin infusion for complications of portal hypertension.
    Am J Gastroenterol. 2025 Jun 11. doi: 10.14309/ajg.0000000000003589.
    >> Share

  57. PEREZ-DIAZ-DEL-CAMPO N, Castelnuovo G, Ferro A, Caviglia GP, et al
    Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease and Associated Comorbidities on Cognitive and Health-Related Quality-of-Life Outcomes in a Mixed Metabolic Dysfunction-Associated Steatotic Liver Disease-Type 2 Diabetes Mellitus Cohor
    Am J Gastroenterol. 2025;120:1779-1790.
    >> Share

  58. SOGBE M, Wong R, Bloomer PM, Steinberg A, et al
    Psychomotor speed from minimal hepatic encephalopathy testing is associated with physical frailty in patients with advanced chronic liver disease.
    Am J Gastroenterol. 2025 Jun 9. doi: 10.14309/ajg.0000000000003583.
    >> Share

    May 2025
  59. DESAI AP, Scherer AN, Serper M
    The Role of Patient-Reported Outcomes in Cirrhosis.
    Am J Gastroenterol. 2025 May 20. doi: 10.14309/ajg.0000000000003551.
    >> Share

  60. HWANG SY, Rezaee-Zavareh MS, Attia AM, Kaymen EA, et al
    Immune-related Adverse Events are Associated with Improved Outcomes after Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Am J Gastroenterol. 2025 May 16. doi: 10.14309/ajg.0000000000003546.
    >> Share

  61. SOUZA M, Al-Sharif L, Diaz I, Khalil SM, et al
    Enrollment in Metabolic Dysfunction-Associated Steatohepatitis Clinical Trials: A Pooled Analysis of Screen Failure Rates.
    Am J Gastroenterol. 2025 May 5. doi: 10.14309/ajg.0000000000003520.
    >> Share

  62. SINGAL AK, Wong RJ, Dasarathy S, Abdelmalek MF, et al
    ACG Clinical Guideline: Malnutrition and Nutritional Recommendations in Liver Disease.
    Am J Gastroenterol. 2025;120:950-972.
    >> Share

  63. THOMAS A
    Continuing Medical Education Questions: May 2025.
    Am J Gastroenterol. 2025;120:948.
    >> Share

    April 2025
  64. WALKER T, Alejandro-Soto A, Nephew L, Jones P, et al
    Association of Social Isolation From Living Alone and Psychological Distress Among Adults With Chronic Liver Disease in the United States.
    Am J Gastroenterol. 2025;120:1860-1864.
    >> Share

  65. SINGAL AG, Yang JD, Jalal PK, Salgia R, et al
    Patient-Perceived Risk of Hepatocellular Carcinoma and Net Benefit of Surveillance: A Multicenter Survey Study.
    Am J Gastroenterol. 2025;120:1800-1808.
    >> Share

  66. MOON AM, Lupu GV, Green EW, Deutsch-Link S, et al
    Rural-urban disparities in hepatocellular carcinoma deaths are driven by hepatitis C-related HCC.
    Am J Gastroenterol. 2025 Apr 11. doi: 10.14309/ajg.0000000000003487.
    >> Share

  67. KUMAR A, Arora A, Choudhury A, Arora V, et al
    Impact of Diabetes, Drug-Induced Liver Injury, and Sepsis on Outcomes in Metabolic Dysfunction Associated Fatty Liver Disease-Related Acute-on-Chronic Liver Failure.
    Am J Gastroenterol. 2025;120:816-826.
    >> Share

    March 2025
  68. GARRIDO-TREVINO L, Ahn S, Tapper EB, Walker OC, et al
    Diagnosis of Acute on Chronic Liver Failure in critically ill patients with cirrhosis using administrative data.
    Am J Gastroenterol. 2025 Mar 17. doi: 10.14309/ajg.0000000000003422.
    >> Share

    February 2025
  69. CHOLANKERIL G, Taylor T, Kramer JR, Liu Y, et al
    Inequalities in developing cirrhosis complications over time: A cohort study.
    Am J Gastroenterol. 2025 Feb 5. doi: 10.14309/ajg.0000000000003354.
    >> Share

  70. YUN B, Park H, Ahn SH, Oh J, et al
    Liver Cancer Risk Across Metabolic Dysfunction-Associated Steatotic Liver Disease and/or Alcohol: A Nationwide Study.
    Am J Gastroenterol. 2025;120:410-419.
    >> Share

    January 2025
  71. DECHARATANACHART P, Poovorawan K, Tangkijvanich P, Charatcharoenwitthaya P, et al
    Cost-Utility Analysis of Non-Invasive Tests to Initiate Hepatocellular Carcinoma Surveillance in Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Am J Gastroenterol. 2025 Jan 29. doi: 10.14309/ajg.0000000000003332.
    >> Share

  72. ROMAIN D, Hao S, Grzyb K, Bashaw L, et al
    Electronic Interventions to Improve Quality for Inpatient Cirrhosis Care: a prospective evaluation.
    Am J Gastroenterol. 2025 Jan 29. doi: 10.14309/ajg.0000000000003334.
    >> Share

  73. GHANDOUR B, Kaplan DE, Mahmud N
    High Cirrhosis Surgical Volume Centers have Reduced Postoperative Mortality in Patients with Cirrhosis Undergoing Major Surgery.
    Am J Gastroenterol. 2025 Jan 21. doi: 10.14309/ajg.0000000000003329.
    >> Share

  74. MORITA M, Takita M, Nishida N, Kudo M, et al
    Giant Sister Mary Joseph;s nodule in Hepatocellular Carcinoma.
    Am J Gastroenterol. 2025 Jan 17. doi: 10.14309/ajg.0000000000003325.
    >> Share

  75. SILVEY S, Patel N, O'Leary JG, Bajaj JS, et al
    ENHANCEMENT OF CIRRHOSIS MORTALITY PREDICTION BY INCLUDING HEPATIC ENCEPHALOPATHY TO MELD3.0 IN A NATIONAL VETERAN COHORT.
    Am J Gastroenterol. 2025 Jan 16. doi: 10.14309/ajg.0000000000003317.
    >> Share

  76. BERAN A, Elfert K, Patel FN, Mohamed M, et al
    Risk of Post-polypectomy Bleeding After Colorectal Endoscopic Mucosal Resection in Patients With Cirrhosis: A Propensity-Matched Analysis of the US Collaborative Network.
    Am J Gastroenterol. 2025 Jan 16. doi: 10.14309/ajg.0000000000003322.
    >> Share

  77. WONG F, Vagas HE, Reddy KR, Pagadala MR, et al
    The Effects of alfapump on Ascites Control and Quality of Life in Patients with Cirrhosis and Recurrent or Refractory Ascites.
    Am J Gastroenterol. 2025 Jan 6. doi: 10.14309/ajg.0000000000003300.
    >> Share

    December 2024
  78. QIAO Y, Yang L, Yang H, Zheng M, et al
    Longitudinal Associations Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Subclinical Cardiovascular Measures in Chinese Children.
    Am J Gastroenterol. 2024;120:1395-1399.
    >> Share

  79. SINGAL AK, Pannerselvam D, Arab JP, Im G, et al
    Delisting From Liver Transplant List for Improvement and Re-compensation Among Decompensated Patients at one-year.
    Am J Gastroenterol. 2024 Dec 23. doi: 10.14309/ajg.0000000000003259.
    >> Share

  80. MALIK S, Frey LJ, Gutman J, Mushtaq A, et al
    Evaluating Artificial Intelligence-Driven Responses to Acute Liver Failure Queries: A Comparative Analysis Across Accuracy, Clarity, and Relevance.
    Am J Gastroenterol. 2024;120:2081-2085.
    >> Share

  81. LEDENKO M, Patel T
    Poverty Traps and Mortality From Liver Diseases in the United States.
    Am J Gastroenterol. 2024;119:2462-2470.
    >> Share

    November 2024
  82. WONG F, Reddy KR, Tandon P, Lai JC, et al
    Sex differences in patient-reported outcomes and perception of ascites burden amongst outpatients with decompensated cirrhosis and ascites.: Sex Differences in Ascites Burden Perception.
    Am J Gastroenterol. 2024 Nov 27. doi: 10.14309/ajg.0000000000003251.
    >> Share

  83. PACHISIA AV, Agarwal A, Mehta S, Kumari A, et al
    Celiac Disease Is Common in Adults With Cryptogenic Cirrhosis and Responds Favorably to Gluten-Free Diet.
    Am J Gastroenterol. 2024 Nov 26. doi: 10.14309/ajg.0000000000003244.
    >> Share

  84. SHAH N, Sanyal AJ
    A PRAGMATIC MANAGEMENT APPROACH FOR METABOLIC DYSFUNCTION ASSOCIATED STEATOSIS AND STEATOHEPATITIS.
    Am J Gastroenterol. 2024 Nov 21. doi: 10.14309/ajg.0000000000003215.
    >> Share

  85. NIE C, Vaska M, Wong JK, Bathe OF, et al
    Tumor Seeding With Needle Biopsy of Hepatocellular Carcinoma: A Systematic Review.
    Am J Gastroenterol. 2024 Nov 14. doi: 10.14309/ajg.0000000000003210.
    >> Share

  86. LAURENZANO J, Ganesan P, Harrington C, Slaughter JC, et al
    Post-Transjugular Intrahepatic Portosystemic Shunt Right Atrial Pressure and Left Atrial Volume Index Predict Heart Failure and Mortality: Dual Center Experience.
    Am J Gastroenterol. 2024 Nov 14. doi: 10.14309/ajg.0000000000003211.
    >> Share

  87. HUANG Y, Huang H, Wei T, Zhang A, et al
    Disparities, Trends, and Predictions to 2040 in Gastrointestinal Cancer Incidence, Mortality in the United States.
    Am J Gastroenterol. 2024;120:1367-1380.
    >> Share

  88. SERPER M, Pulaski ME, Zhang S, Taddei TH, et al
    Albumin for Spontaneous Bacterial Peritonitis: Care Variation, Disparities, and Outcomes.
    Am J Gastroenterol. 2024;120:2059-2071.
    >> Share

  89. BATHEJA MA
    Continuing Medical Education Questions: November 2024.
    Am J Gastroenterol. 2024;119:2172.
    >> Share

  90. SINGAL AG, Parikh ND, Shetty K, Han SH, et al
    Natural History of Indeterminate Liver Nodules in Patients With Advanced Liver Disease: A Multicenter Retrospective Cohort Study.
    Am J Gastroenterol. 2024;119:2251-2258.
    >> Share

    October 2024
  91. BHUSHAN S, Sohal A, Kowdley KV, Agaf FF, et al
    Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Therapy Landscape.
    Am J Gastroenterol. 2024 Oct 31. doi: 10.14309/ajg.0000000000003174.
    >> Share

  92. MURNANE PM, Afshar M, Chamie G, Cook RL, et al
    Using Phosphatidylethanol as an Adjunct to Self-Reported Alcohol Use Improves Identification of Liver Fibrosis Risk.
    Am J Gastroenterol. 2024;120:1567-1575.
    >> Share

  93. CHEN VL, Oliveri A, Raut C, Chen Y, et al
    TM6SF2-rs58542926 genotype has opposing effects on incidence of hepatic and cardiac events in a community cohort: TM6SF2 effects on liver and cardiac outcomes.
    Am J Gastroenterol. 2024 Oct 30. doi: 10.14309/ajg.0000000000003169.
    >> Share

  94. HASJIM BJ, Harris A, Balbale SN, Obayemi JE, et al
    Social Disadvantage and Disparities in Chronic Liver Disease: A Systematic Review.
    Am J Gastroenterol. 2024;120:1548-1566.
    >> Share

  95. KIM NJ, Vutien P, Borgerding JA, Beste LA, et al
    Hepatic steatosis estimated by VCTE-derived CAP scores was associated with lower risks of liver-related events and all-cause mortality in patients with chronic liver disease.
    Am J Gastroenterol. 2024 Oct 25. doi: 10.14309/ajg.0000000000003161.
    >> Share

  96. UFERE NN, Zeng C, Donlan J, Shalev D, et al
    Psychological Distress is Prevalent and Interdependent Among Patients with Decompensated Cirrhosis and Their Caregivers.
    Am J Gastroenterol. 2024 Oct 25. doi: 10.14309/ajg.0000000000003158.
    >> Share

  97. MOON AM
    Raising the Bar: Is Hepatocellular Carcinoma Surveillance Warranted for Patients With Alcohol-Associated Cirrhosis?
    Am J Gastroenterol. 2024 Oct 24. doi: 10.14309/ajg.0000000000003123.
    >> Share

  98. BARRITT AS 4TH, Hayashi PH, Stolz AA, Barnhart H, et al
    Refinement of Hy Law Using the Drug-Induced Liver Injury Network Database.
    Am J Gastroenterol. 2024;120:1307-1313.
    >> Share

  99. CIRICILLO J, Myer A, Yeboah-Korang A, Osman A, et al
    Improving the Diagnostic Accuracy of RECAM in North American Patients With Suspected Idiosyncratic Drug-Induced Liver Injury.
    Am J Gastroenterol. 2024;120:1325-1333.
    >> Share

  100. JM E, E V, Nm I
    Predicting and preventing bleeding in patients with cirrhosis undergoing procedures.
    Am J Gastroenterol. 2024 Oct 9. doi: 10.14309/ajg.0000000000003129.
    >> Share

  101. VERMA N, Roy A, Valsan A, Garg P, et al
    Liver Dysfunction and Systemic Inflammation Drive Organ Failures in Acute Decompensation of Cirrhosis: A Multi-Centric Study.
    Am J Gastroenterol. 2024 Oct 4. doi: 10.14309/ajg.0000000000003115.
    >> Share

  102. LANZ-ZUBIRIA L, Chavez-Tapia NC
    To Continue or Discontinue beta-Blockers in Secondary Prophylaxis? That is the Dilemma.
    Am J Gastroenterol. 2024;119:2143.
    >> Share

  103. TANAKA T, Vander Weg M, Jones MP, Wehby G, et al
    Assessment of the 2021 AASLD Practice Guidance for Albumin Infusion in Elective Therapeutic Paracentesis: A Regression Discontinuity Design.
    Am J Gastroenterol. 2024;119:2045-2051.
    >> Share

  104. ZAVER HB, Rajpal N, Shah NL, Argo CK, et al
    MELD and MELD 3.0: What It Means for Your Practice.
    Am J Gastroenterol. 2024;119:1951-1954.
    >> Share

    September 2024
  105. JUTRAS G, Flemming JA
    Global Epidemiology of Cirrhosis in Women.
    Am J Gastroenterol. 2024 Sep 19. doi: 10.14309/ajg.0000000000003086.
    >> Share

  106. JENSEN MD, West PJ, Crooks C, Morling JR, et al
    Primary liver cancer risk and mortality in patients with alcohol-related cirrhosis in England and Denmark: observational cohort studies.
    Am J Gastroenterol. 2024 Sep 9. doi: 10.14309/ajg.0000000000003077.
    >> Share

  107. SILVEY S, Patel NR, Tsai SY, Nadeem M, et al
    Higher Rate of SBP Recurrence with Secondary SBP Prophylaxis Compared to No Prophylaxis in Two National Cirrhosis Cohorts.
    Am J Gastroenterol. 2024 Sep 4. doi: 10.14309/ajg.0000000000003075.
    >> Share

  108. WONG RJ, Yang Z, Yeoh A, Do A, et al
    Impact of HIV Infection on Liver and Cardiovascular Outcomes in Veterans With Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Am J Gastroenterol. 2024;119:1841-1848.
    >> Share

    August 2024
  109. KRONSTEN VT, Shawcross DL
    Clinical implications of inflammation in patients with cirrhosis.
    Am J Gastroenterol. 2024 Aug 27. doi: 10.14309/ajg.0000000000003056.
    >> Share

  110. KOWDLEY KV, Hirschfield GM, Coombs C, Malecha ES, et al
    COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.
    Am J Gastroenterol. 2024 Aug 14. doi: 10.14309/ajg.0000000000003029.
    >> Share

  111. LI M, Shu W, Zou Y, Xiao H, et al
    Reversing Metabolic Dysfunction-Associated Steatotic Liver Disease Promotes Healthy Pediatric Cardiovascular Structures: The PROC Study.
    Am J Gastroenterol. 2024;119:1640-1643.
    >> Share

  112. BARRITT AS 4TH, Yu F, Mospan AR, Newsome PN, et al
    High Concordance Between Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease in the TARGET-NASH Real-World Cohort.
    Am J Gastroenterol. 2024;119:1624-1627.
    >> Share

  113. VANDERSCHUEREN E, Armandi A, Kwanten W, Cassiman D, et al
    Spleen Stiffness-Based Algorithms Are Superior to Baveno VI Criteria to Rule Out Varices Needing Treatment in Patients With Advanced Chronic Liver Disease.
    Am J Gastroenterol. 2024;119:1515-1524.
    >> Share

  114. STERLING RK, Vilar-Gomez E, Wilson LA, Loomba R, et al
    Diagnostic Ability of Simple Noninvasive Blood Tests to Predict Increased Liver Stiffness in People Living With HIV and Steatotic Liver Disease.
    Am J Gastroenterol. 2024;119:1483-1495.
    >> Share

  115. FONTANA RJ, Li YJ, Vuppalanchi R, Kleiner DE, et al
    ERAP-1 and ERAP-2 Variants in Liver Injury After COVID-19 mRNA Vaccination: A US Multicenter Study.
    Am J Gastroenterol. 2024;119:1496-1505.
    >> Share

  116. LIU C, Cao Z, Yan H, Wong YJ, et al
    Correction to: A Novel SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102): An International Multicenter Cohort Study.
    Am J Gastroenterol. 2024;119:1706.
    >> Share

    July 2024
  117. WANG RX, Serper M, Taddei TH, Kaplan DE, et al
    The Association Between Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Exposure and Key Cirrhosis-Related Outcomes.
    Am J Gastroenterol. 2024 Jul 25. doi: 10.14309/ajg.0000000000002976.
    >> Share

  118. SHENOY A, Valicevic AN, Lin A, Su GL, et al
    Delivery of Outpatient Cirrhosis Care Via Tele-visit is Not Associated with Increased Mortality as Compared to Traditional In-Person Visits.
    Am J Gastroenterol. 2024 Jul 25. doi: 10.14309/ajg.0000000000002979.
    >> Share

  119. TAPPER EB, Goldberg D, Parikh ND, Terrault NA, et al
    The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints.
    Am J Gastroenterol. 2024 Jul 17. doi: 10.14309/ajg.0000000000002953.
    >> Share

  120. KAZUMORI H, Saima A, Ohno Y
    Development of Giant Hepatocellular Carcinoma Leads to Biliary Plastic Stent Compression Resulting in Pseudoaneurysm Rupture in Right Hepatic Artery.
    Am J Gastroenterol. 2024 Jul 8. doi: 10.14309/ajg.0000000000002938.
    >> Share

  121. ARTZNER T, Goldberg DS, Sundaram V, Faitot F, et al
    Improvement in survival after transplantation for critically ill patients with cirrhosis in the United States.
    Am J Gastroenterol. 2024 Jul 5. doi: 10.14309/ajg.0000000000002944.
    >> Share

  122. LOUISSAINT J, Kyalwazi B, Deng J, Melendez-Torres J, et al
    Patients With Cirrhosis Rapidly Review Potentially Abnormal Hepatocellular Carcinoma Surveillance Results Through the Patient Portal.
    Am J Gastroenterol. 2024 Jul 3. doi: 10.14309/ajg.0000000000002940.
    >> Share

  123. FRENETTE C, Mendiratta-Lala M, Salgia R, Wong RJ, et al
    ACG Clinical Guideline: Focal Liver Lesions.
    Am J Gastroenterol. 2024;119:1235-1271.
    >> Share

  124. ASKGAARD G, Jepsen P, Jensen MD, Kann AE, et al
    Population-Based Study of Alcohol-Related Liver Disease in England in 2001-2018: Influence of Socioeconomic Position.
    Am J Gastroenterol. 2024;119:1337-1345.
    >> Share

    June 2024
  125. HUANG SC, Su TH, Tseng TC, Liao SH, et al
    Pre-existing and new-onset metabolic dysfunctions increase cirrhosis and its complication risks in chronic hepatitis B.
    Am J Gastroenterol. 2024 Jun 26. doi: 10.14309/ajg.0000000000002915.
    >> Share

  126. BERAN A, Mohamed MFH, Vargas A, Aboursheid T, et al
    Early Diagnostic Paracentesis Improves Outcomes of Hospitalized Patients with Cirrhosis and Ascites: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2024 Jun 25. doi: 10.14309/ajg.0000000000002906.
    >> Share

  127. ELHENCE H, Dodge JL, Kahn JA, Lee BP, et al
    Characteristics and Outcomes Among U.S. Commercially Insured Transgender Adults with Cirrhosis: A National Cohort Study.
    Am J Gastroenterol. 2024 Jun 25. doi: 10.14309/ajg.0000000000002907.
    >> Share

  128. PARVATANENI S, Sarkis Y, Haugh M, Baker B, et al
    A comprehensive evaluation of emergency department utilization by patients with cirrhosis.
    Am J Gastroenterol. 2024 Jun 24. doi: 10.14309/ajg.0000000000002905.
    >> Share

  129. THABUT D, Rudler M, Weiss N
    Diagnosis of Overt Hepatic Encephalopathy With a New Algorithm: Follow-up Data Are Required.
    Am J Gastroenterol. 2024 Jun 3. doi: 10.14309/ajg.0000000000002856.
    >> Share

  130. PAIK JM, Duong S, Zelber-Sagi S, Lazarus JV, et al
    Food Insecurity, Low Household Income, and Low Education Level Increase the Risk of Having Metabolic Dysfunction-Associated Fatty Liver Disease Among Adolescents in the United States.
    Am J Gastroenterol. 2024;119:1089-1101.
    >> Share

    May 2024
  131. DANPANICHKUL P, Ng CH, Muthiah M, Suparan K, et al
    From Shadows to Spotlight: Exploring the Escalating Burden of Alcohol-Associated Liver Disease and Alcohol Use Disorder in Young Women.
    Am J Gastroenterol. 2024;119:893-909.
    >> Share

    April 2024
  132. BAJAJ JS, Pimentel M
    Is Hepatic Encephalopathy the First True Disorder of Gut-Brain interaction?
    Am J Gastroenterol. 2024 Apr 22. doi: 10.14309/ajg.0000000000002824.
    >> Share

  133. HUME SJ, Holmes JA, Thompson AJ
    Individualizing the Approach to Stopping Nucleos(t)ide Analogs: Can We Use a Low HBsAg Threshold to Predict a High Chance of Functional Cure and Minimal Risk of Hepatic Decompensation?
    Am J Gastroenterol. 2024 Apr 15. doi: 10.14309/ajg.0000000000002766.
    >> Share

  134. ERMINELLI D, Mangini C, Zarantonello L, Angeli P, et al
    Overt hepatic encephalopathy - more than meets the eye.
    Am J Gastroenterol. 2024 Apr 8. doi: 10.14309/ajg.0000000000002795.
    >> Share

  135. KHANNA S, Shah NL, Argo CK
    Use of Phosphatidylethanol Testing in Patients With Liver Disease.
    Am J Gastroenterol. 2024;119:596-599.
    >> Share

  136. PERUMALSWAMI PV, Winder GS, Fernandez AC, Mellinger JL, et al
    Practical Considerations to Optimize Care for Patients With Alcohol-Associated Liver Disease in General Gastroenterology Practice.
    Am J Gastroenterol. 2024;119:591-595.
    >> Share

    March 2024
  137. CHEN YT, Chen TI, Yang TH, Yin SC, et al
    Long-term Risks for Cirrhosis and Hepatocellular Carcinoma Across Steatotic Liver Disease Subtypes.
    Am J Gastroenterol. 2024 Mar 27. doi: 10.14309/ajg.0000000000002778.
    >> Share

  138. CHEN QF, Chen S, Yi JZ, Wang JL, et al
    Recommended Ten Years' Follow-Up Strategy for Small Hepatocellular Carcinoma after Radiofrequency Ablation: A Cost-Effectiveness Evaluation.
    Am J Gastroenterol. 2024 Mar 25. doi: 10.14309/ajg.0000000000002774.
    >> Share

  139. LO GH, Yeh JH, Tseng CH, Chen TH, et al
    A non-inferiority trial comparing 2 days vs. 5 days of terlipressin and ceftriaxone in terms of 5-day rebleeding for patients with acute gastro-esophageal variceal hemorrhage.
    Am J Gastroenterol. 2024 Mar 25. doi: 10.14309/ajg.0000000000002776.
    >> Share

  140. TABISH M, Agarwal S, Gopi S, Rana R, et al
    Randomized controlled trial of Intravenous ferric-carboxymaltose vs oral iron to treat iron deficiency anemia after variceal bleed in patients with cirrhosis.
    Am J Gastroenterol. 2024 Mar 22. doi: 10.14309/ajg.0000000000002775.
    >> Share

  141. SAMALA N, Xin Y, Wilson LA, Yates K, et al
    Non-Hispanic Black persons with nonalcoholic fatty liver disease have lower rates of advanced fibrosis, cirrhosis, and liver-related events even after controlling for clinical risk factors and PNPLA3 genotype.
    Am J Gastroenterol. 2024 Mar 14. doi: 10.14309/ajg.0000000000002756.
    >> Share

  142. HIRODE G, Hansen BE, Chen CH, Su TH, et al
    Erratum: Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).
    Am J Gastroenterol. 2024 Mar 8. doi: 10.14309/ajg.0000000000002718.
    >> Share

  143. ZHANG X, Daniel CR, Soltero V, Vargas X, et al
    A Study of Dietary Patterns Derived by Cluster Analysis and Their Association With Metabolic Dysfunction-Associated Steatotic Liver Disease Severity Among Hispanic Patients.
    Am J Gastroenterol. 2024;119:505-511.
    >> Share

    February 2024
  144. SASAKI S, Schmidt S, Uldry E, Halkic N, et al
    Hepaticocholecystic Duct: Not a Myth but a Pitfall in Cholecystectomy.
    Am J Gastroenterol. 2024 Feb 19. doi: 10.14309/ajg.0000000000002725.
    >> Share

  145. LOUISSAINT J, Vargas HE
    Picture Perfect: Artificial Intelligence in the Management of Hepatic Encephalopathy.
    Am J Gastroenterol. 2024 Feb 16. doi: 10.14309/ajg.0000000000002659.
    >> Share

  146. BUI H, Kumar NG, Singal AG, Boparai J, et al
    Implementation of a hepatocellular carcinoma surveillance program in a community-based integrated health system in patients with hepatitis C cirrhosis.
    Am J Gastroenterol. 2024 Feb 9. doi: 10.14309/ajg.0000000000002704.
    >> Share

  147. RANGRAY R
    Continuing Medical Education Questions: February 2024.
    Am J Gastroenterol. 2024;119:248.
    >> Share

  148. BATHEJA MA
    Continuing Medical Education Questions: February 2024.
    Am J Gastroenterol. 2024;119:247.
    >> Share

  149. MURPHY CC, Tavakkoli A, Wani S, Singal AG, et al
    Pandemic-Related Changes in Incidence and Mortality Rates of Gastrointestinal Cancers During 2020.
    Am J Gastroenterol. 2024;119:382-387.
    >> Share

  150. JULIEN J, Ayer T, Tapper EB, Chhatwal J, et al
    The Rising Costs of Alcohol-Associated Liver Disease in the United States.
    Am J Gastroenterol. 2024;119:270-277.
    >> Share

    January 2024
  151. GE J, Chen IY, Pletcher MJ, Lai JC, et al
    How I Approach It: Prompt Engineering for Generative Artificial Intelligence (GAI) in Gastroenterology and Hepatology.
    Am J Gastroenterol. 2024 Jan 31. doi: 10.14309/ajg.0000000000002689.
    >> Share

  152. CHARA BS, Hara KS, Penrice D, Schmidt KA, et al
    ARTIFICIAL INTELLIGENCE-ENABLED STOOL ANALYSIS FOR LACTULOSE TITRATION ASSISTANCE IN HEPATIC ENCEPHALOPATHY VIA A SMARTPHONE APPLICATION.
    Am J Gastroenterol. 2024 Jan 19. doi: 10.14309/ajg.0000000000002656.
    >> Share

  153. BLOOM PP, Bajaj JS
    The Current and Future State of Microbiome Therapeutics in Liver Disease.
    Am J Gastroenterol. 2024;119.
    >> Share

  154. KARNA R
    Continuing Medical Education Questions: January 2024.
    Am J Gastroenterol. 2024;119:27.
    >> Share

  155. NICOLETTI P, Dellinger A, Li YJ, Barnhart H, et al
    HLA-B*53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans.
    Am J Gastroenterol. 2024;119:200-202.
    >> Share

    December 2023
  156. FAGAN A, Gallagher ML, Mousel T, Davis BC, et al
    AI evaluation of Stool Quality Guides Management of Hepatic Encephalopathy using a Smartphone App.
    Am J Gastroenterol. 2023 Dec 28. doi: 10.14309/ajg.0000000000002646.
    >> Share

  157. MUI BG, Grinspan LT, Crismale JF
    Variations in practice among cirrhotic patients with portal vein thrombosis and esophageal varices: a North American survey study.
    Am J Gastroenterol. 2023 Dec 26. doi: 10.14309/ajg.0000000000002640.
    >> Share

  158. MULGAONKAR A, Huang DQ, Siddiqi H, Fowler K, et al
    Cost-Effectiveness Analysis of HCC Surveillance in Nonalcoholic Fatty Liver Disease Cirrhosis using US Visualization Score C-Triggered Abbreviated MRI.
    Am J Gastroenterol. 2023 Dec 26. doi: 10.14309/ajg.0000000000002636.
    >> Share

  159. PRICE JC, Springer G, Seaberg EC, Budoff MJ, et al
    High incidence rate of CT-measured steatotic liver disease in men with and without HIV infection.
    Am J Gastroenterol. 2023 Dec 22. doi: 10.14309/ajg.0000000000002633.
    >> Share

  160. LEE JD, Gounko D, Lee JA, Mukherjee T, et al
    Assisted Reproductive Technology Treatment Outcomes in Women With Liver Disease.
    Am J Gastroenterol. 2023;118:2184-2190.
    >> Share

    November 2023
  161. DAHER D, El Dahan KS, Yekkaluri S, Gopal P, et al
    Proportion Time Covered by Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
    Am J Gastroenterol. 2023 Nov 17. doi: 10.14309/ajg.0000000000002596.
    >> Share

  162. HASHMI I, Chadha N, McIntosh G, Sterling R, et al
    Quality Improvement for Health Care Providers in Gastroenterology and Hepatology.
    Am J Gastroenterol. 2023 Nov 17. doi: 10.14309/ajg.0000000000002609.
    >> Share

  163. KULKARNI AV, Avadhanam M, Karandikar P, Rakam K, et al
    Antibiotics with or without Rifaximin for acute hepatic Encephalopathy in critically ill patients with cirrhosis: A double-blind, randomized controlled (ARiE) trial.
    Am J Gastroenterol. 2023 Nov 9. doi: 10.14309/ajg.0000000000002575.
    >> Share

  164. BAJAJ JS, Kamath PS, Reddy KR, Asrani SK, et al
    Predictors of Respiratory Failure Development in A Multi-Center Cohort of Inpatients with Cirrhosis.
    Am J Gastroenterol. 2023 Nov 8. doi: 10.14309/ajg.0000000000002574.
    >> Share

  165. PATEL A, Bowman CA, Prause N, Kilaru SM, et al
    Outcomes of a Three-Year Quality Improvement Study to Improve Advance Care Planning in Patients with Decompensated Cirrhosis.
    Am J Gastroenterol. 2023 Nov 7. doi: 10.14309/ajg.0000000000002570.
    >> Share

  166. WANG B, Zhou J, Wu X, Sun Y, et al
    Carvedilol plus NUCs for compensated HBV-cirrhosis patients under virological suppression: a randomised, open-label trial.
    Am J Gastroenterol. 2023 Nov 6. doi: 10.14309/ajg.0000000000002569.
    >> Share

  167. YAGHOOBI M
    Continuing Medical Education Questions: November 2023.
    Am J Gastroenterol. 2023;118:1925.
    >> Share

  168. KIM J, Zhang Y, Kim H, Zhang Y, et al
    A Comparative Study of Healthy Dietary Patterns for Incident and Fatal Digestive System Cancer.
    Am J Gastroenterol. 2023;118:2061-2070.
    >> Share

  169. SQUIZZATO F, Abruzzino G, Piazza M
    Acute Liver Failure in a Patient With Previous Vascular Surgery for Bowel Ischemia.
    Am J Gastroenterol. 2023;118:1919.
    >> Share

  170. CHO Y, Chang Y, Ryu S, Kim C, et al
    History of Gestational Diabetes and Incident Nonalcoholic Fatty Liver Disease: The Kangbuk Samsung Health Study.
    Am J Gastroenterol. 2023;118:1980-1988.
    >> Share

    October 2023
  171. LV XH, Lu Q, Deng K, Yang JL, et al
    Prevalence and characteristics of covert/minimal hepatic encephalopathy in patients with liver cirrhosis: A systematic review and meta-analysis.
    Am J Gastroenterol. 2023 Oct 19. doi: 10.14309/ajg.0000000000002563.
    >> Share

  172. SILKE L, Donata G, Dominik G, Uli F, et al
    Endoscopic features of post-COVID-19 cholangiopathy and its management using ERCP.
    Am J Gastroenterol. 2023 Oct 16. doi: 10.14309/ajg.0000000000002562.
    >> Share

  173. OZTURK NB, Jamil LH, Tapper EB
    Diagnostic Performance of the ICD-10 Code K76.82 for Hepatic Encephalopathy in Patients with Cirrhosis.
    Am J Gastroenterol. 2023 Oct 13. doi: 10.14309/ajg.0000000000002560.
    >> Share

  174. PRASOPPOKAKORN T, Panarat P
    Disseminated Melioidosis infection involving hepatosplenomegaly and massive extramedullary hematopoiesis.
    Am J Gastroenterol. 2023 Oct 4. doi: 10.14309/ajg.0000000000002549.
    >> Share

  175. PULASKI M, Bittermann T, Taddei TH, Kaplan DE, et al
    The Association between Homelessness and Key Liver-Related Outcomes in Veterans with Cirrhosis.
    Am J Gastroenterol. 2023 Oct 2. doi: 10.14309/ajg.0000000000002535.
    >> Share

  176. ONG J, Mandour MO, Allison M
    Endoscopic Gastric Plication in Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2023;118:1899.
    >> Share

    September 2023
  177. NACHEF C, Bousson V, Belmatoug N, Cohen-Solal M, et al
    Osteoporosis and fragility fractures in patients with cirrhosis evaluated for liver transplantation: Identification of high-risk patients based on computed tomography at evaluation.
    Am J Gastroenterol. 2023 Sep 20. doi: 10.14309/ajg.0000000000002507.
    >> Share

  178. FENG X, Li H, Bajaj J, Moon AM, et al
    Endoscopic Ultrasound (EUS)-guided Sclerotherapy with Lauromacrogol: A Novel Therapy for A Giant Esophageal Hemangioma.
    Am J Gastroenterol. 2023 Sep 20. doi: 10.14309/ajg.0000000000002514.
    >> Share

    July 2023
  179. LARINO-NOIA J, Fernandez-Castroagudin J, de la Iglesia-Garcia D, Lazare H, et al
    Quality of Tissue Samples Obtained by Endoscopic Ultrasound-Guided Liver Biopsy: A Randomized, Controlled Clinical Trial.
    Am J Gastroenterol. 2023 Jul 14. doi: 10.14309/ajg.0000000000002375.
    >> Share

    March 2023
  180. LIU Y, Guo G, Zheng L, Sun R, et al
    Effectiveness of fenofibrate in treatment-naive patients with primary biliary cholangitis: A Randomized Clinical Trial.
    Am J Gastroenterol. 2023 Mar 9. doi: 10.14309/ajg.0000000000002238.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016